Original Research

Risk of brain metastasis reduced after erlotinib treatment in advanced pulmonary adenocarcinoma patients with sensitive EGFR mutation

Liu J, Xing L, Meng X, Yue J, Meng X, Xie P, Li X, Kong L, Yu J

OncoTargets and Therapy 2016, 9:671-679

Published Date: 5 February 2016